With $32M loan, connected glucometer pioneer AgaMatrix will split company into CGM, BGM businesses | MobiHealthNews
Biosensor market to double to $40 billion by 2026 | Fierce Electronics
Artificial Pancreas' Best in Poorly Controlled Type 1 Diabetes
AgaMatrix | Innovative Products for Diabetes Care
Comparison Between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial | Diabetes Technology & Therapeutics
Diabetes Technology Society
PCSK9 inhibition in children with familial hypercholesterolaemia
Company | Waveform
WaveForm Technologies Inc Awarded CE Mark Approval
Bayer, WaveForm in tie-up for glucose monitoring solutions for China - Chinadaily.com.cn
With $32M loan, connected glucometer pioneer AgaMatrix will split company into CGM, BGM businesses | MobiHealthNews
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial | Nature Medicine
WaveForm Technologies Inc. Awarded CE Mark Approval for Their Continuous Glucose Monitoring System
Reorganization, and Formation of WaveForm Technologies Inc.
Update and Advances in Technology For Diabetes Self Management PDF | PDF | Diabetes Mellitus | Mobile App
Reorganization, and Formation of WaveForm Technologies Inc.
Comparison of Automated Insulin Delivery Systems - Diabetesnet.com
Assessment of a Decision Support System for Adults with Type 1 Diabetes on Multiple Daily Insulin Injections | Diabetes Technology & Therapeutics
WaveForm Gets Favorable Decision on Glucose Monitoring Patents
AgaMatrix | Innovative Products for Diabetes Care
About | Waveform
Glucose Meters | AgaMatrix
AgaMatrix Announces Reorganization, and Formation of WaveForm Technologies Inc.
